The primary reason for high mortality rates among cancer patients is metastasis, where
tumor cells migrate through the bloodstream from the original site to other parts of the body …

Cell-free DNA (cfDNA) is easily accessible in peripheral blood and can be used as
biomarkers for cancer diagnostics, prognostics, and therapeutics. The applications of cfDNA …

Blood circulating cell-free DNA (ccfDNA) is a suggested biosource of valuable clinical
information for cancer, meeting the need for a minimally-invasive advancement in the route …

There is a strong demand for the identification of new biomarkers in colorectal cancer (CRC)
diagnosis. Among all liquid biopsy analysts, cell-free circulating DNA (cfDNA) is probably …

DNA methylation profiles are in dynamic equilibrium via the initiation of methylation,
maintenance of methylation and demethylation, which control gene expression and …

Circulating tumour DNA (ctDNA) has emerged as a promising blood-based biomarker for
monitoring disease status of patients with advanced cancers. In melanoma, ctDNA has been …

Circulating cell‐free DNA (cfDNA) was found in increased amounts in cancer patients and
tumor‐associated molecular alteration can be detected in cancer patient's samples. For this …

Over the last four decades, methodological innovations have continuously changed
transcriptome profiling. It is now feasible to sequence and quantify the transcriptional outputs …

Simple Summary Patients with colorectal cancer without distant metastases are often cured
by surgical tumor resection. Follow-up is needed because of the risk of disease recurrence …

The application of circulating tumor DNA (ctDNA) represents a non-invasive method for
tumor detection. Its prognostic significance in patients with colorectal cancer is controversial …